Promentis Pharmaceuticals, Inc. is a biopharmaceutical company based in Milwaukee, Wisconsin, established in 2006. The company specializes in developing therapies for neuropsychiatric disorders, focusing on treatments that address glutamatergic imbalance and oxidative stress. Promentis is advancing compounds such as SXC-2023, which targets System xc- to treat conditions including impulse control disorders and obsessive-compulsive disorder. Additionally, Promentis has intentions to develop a new antipsychotic drug aimed at treating schizophrenia, positioning itself to address significant unmet medical needs in the field of mental health.
Private Equity Round in 2011
igobubble is a unique social discovery tool built on Darwinian principles of evolution. Users discover, create and share photos, videos and messages inside growing virtual bubbles at any real world location.
Helps the user organically meet new people nearby through content sharing and creation. Users can leave their bubble marks wherever they go and track all other users who interact with them.
Private Equity Round in 2010
The Hantec Markets company culture is centred on one simple philosophy Trust Through Transparency. Based in the UK, Hantec's mission is to provide currency trading technology combined with quality execution, and experienced 1st class customer support. At the heart of our success is the world renowned trading platform MetaTrader 4 and Currenex the liquidity provider to financial institutions. Founded in 1990, the Hantec Group has undergone dynamic expansion by extending its network from China to Japan, Australia, New Zealand, and now Europe.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.